Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by<i>Enterobacter</i>,<i>Citrobacter</i>or<i>Serratia</i>species: a systematic review with meta-analysis
Patrick N. A. Harris(University of Technology Sydney), David L. Paterson(The University of Queensland), Rachel Huxley(University of Queensland), Jane Y. Wei(University of Queensland), Andrew Shen(University of Queensland), Kyungmin Huh(Armed Forces Capital Hospital), Ahmed A. Abdile(University of Auckland), Thomas R. Talbot(Vanderbilt University), Catherine O’Neal(Louisiana State University Health Sciences Center New Orleans), Nirmala Pandeya(University of Queensland), Stuart Paynter(University of Queensland), Yohei Doi(Fujita Health University)
Cited by 86
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Antimicrobial Resistance in ESKAPE Pathogens
|Clinical Microbiology Reviews|2020|2k
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
The emerging threat of multidrug-resistant Gram-negative bacteria in urology
|Nature Reviews Urology|2015|367